A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Public ClinicalTrials.gov record NCT06481592. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Open-label Study of Lifileucel (Tumor-infiltrating Lymphocytes [TIL]) in Participants With Previously Treated Advanced Endometrial Cancer.
Study identification
- NCT ID
- NCT06481592
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Iovance Biotherapeutics, Inc.
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- Lifileucel Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- Female
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 28, 2024
- Primary completion
- Apr 30, 2028
- Completion
- Oct 31, 2029
- Last update posted
- Oct 29, 2025
2024 – 2029
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Honor Health | Phoenix | Arizona | 85016 | Recruiting |
| University of Southern California | Los Angeles | California | 90007 | Recruiting |
| Orlando Health | Orlando | Florida | 32806 | Recruiting |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | Tampa | Florida | 33612 | Recruiting |
| Augusta University | Augusta | Georgia | 30912 | Recruiting |
| UofL Health - Brown Cancer Center | Louisville | Kentucky | 40202 | Recruiting |
| Barbara Ann Karmanos Cancer Hospital | Detroit | Michigan | 48201 | Recruiting |
| Roswell Park Cancer Institute | Buffalo | New York | 14203 | Recruiting |
| University of Oklahoma | Oklahoma City | Oklahoma | 73117 | Recruiting |
| Allegheny Health | Pittsburgh | Pennsylvania | 15524 | Recruiting |
| Avera Medical Group Oncology | Sioux Falls | South Dakota | 57105 | Recruiting |
| MD Anderson Cancer Center - U of Texas | Houston | Texas | 77030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06481592, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 29, 2025 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06481592 live on ClinicalTrials.gov.